Hims & Hers Health Shares Fall on Rating, Target-Price Cuts
marketwatch.com
news
2022-10-17 16:15:00

By Sabela Ojea Shares of Hims & Hers Health Inc. on Monday fell after receiving a rating and target-price cut from Piper Sandler. The recommendation on the stock of the company, whose platform connects patients to licensed healthcare professionals, was cut to "neutral" from "overweight" by the investment bank. Hims & Hers's target price was also reduced to $6 a share from $8 a share by Piper Sandler. At 12:00 p.m. EDT shares down 6.2%, at $4.47. Write to Sabela Ojea at sabela.ojea@wsj.com
